The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 18, 2022

Filed:

Sep. 28, 2020
Applicant:

Jiangsu Academy of Agricultural Sciences, Nanjing, CN;

Inventors:

Jin Chen, Nanjing, CN;

Xiaoming Yu, Nanjing, CN;

Qisheng Zheng, Nanjing, CN;

Liting Hou, Nanjing, CN;

Yiwei Wang, Nanjing, CN;

Yuanpeng Zhang, Nanjing, CN;

Xuwen Qiao, Nanjing, CN;

Jibo Hou, Nanjing, CN;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/39 (2006.01); A61K 39/135 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 39/39 (2013.01); A61K 39/135 (2013.01); A61K 2039/5252 (2013.01); A61K 2039/5555 (2013.01); A61K 2039/55572 (2013.01); A61K 2039/55583 (2013.01);
Abstract

The present invention relates to the preparation of the compound immunopotentiator and the application thereof in a foot-and-mouth disease vaccine of pigs. According to the present invention, the foot-and-mouth disease vaccine of pigs is taken as a research subject, and on this basis, several immunopotentiators having obvious immunopotentiating effects are selected for the compound immunopotentiator, and an antigen/vaccine is mixed with the immunopotentiator to prepare a vaccine-immunized pig. An animal experiment result shows that the present invention has obvious immunopotentiating effects. After immunizing the vaccine containing the compound immunopotentiator, a window period for antibody production can be significantly shortened to 7 days; a LPB-ELISA antibody titer is significantly improved, and an antibody pass rate is significantly increased; an immune protection period is also significantly extended, at least up to 7 months.


Find Patent Forward Citations

Loading…